" class="no-js "lang="en-US"> Karan Arora - Medtech Alert
Friday, January 17, 2025

Breaking News

Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Astellas and Cullgen Enter into Strategic Collaboration and Option Agreement to Advance Innovative Targeted Protein Degraders Auxilius Pharma Raises Seed Funding of $1 Million and Commences its Clinical Program Captivate Bio and EverCell Bio partner on Human Cell Modeling Services for Cell and Gene Therapy Markets Applied StemCell Partners with CIRM to Provide Clinical-Grade iPSCs and Access to Its Proprietary Gene Editing Technologies Alentis Therapeutics Receives IND Clearance from FDA for ALE.C04 for the Treatment of CLDN1+ Tumors
Karan Arora

Karan Arora

About Karan Arora

Karan Arora currently serves as Chief Commercial Digital Officer Global Vice President at AstraZeneca. He is a visionary leader with P&L experience focused on driving business growth fueled by Digital, Data, Advanced Analytics.

Related Story

Health Apps

 Huma and AstraZeneca Partner to Accelerate Innovation for Digital-First Patient Care | Pharmtech Focus

Huma and AstraZeneca Partner to Accelerate Innovation for Digital-First Patient Care

March 23 2022

Huma Therapeutics Limited, a global digital health technology company advancing digital-first care delivery and research […]